- Report
- August 2022
- 325 Pages
Global
From €3139EUR$3,500USD£2,691GBP
- Report
- August 2020
- 292 Pages
Global
From €3139EUR$3,500USD£2,691GBP
- Report
- April 2020
- 233 Pages
Global
From €3139EUR$3,500USD£2,691GBP
- Report
- May 2024
- 289 Pages
Global
From €4484EUR$5,000USD£3,845GBP
- Report
- August 2025
- 197 Pages
Global
From €3179EUR$3,545USD£2,726GBP
€3532EUR$3,939USD£3,029GBP
- Report
- August 2025
- 190 Pages
Global
From €3179EUR$3,545USD£2,726GBP
€3532EUR$3,939USD£3,029GBP
- Report
- August 2025
- 190 Pages
Global
From €3179EUR$3,545USD£2,726GBP
€3532EUR$3,939USD£3,029GBP
- Report
- August 2025
- 191 Pages
Global
From €3179EUR$3,545USD£2,726GBP
€3532EUR$3,939USD£3,029GBP
- Report
- August 2025
- 195 Pages
Global
From €3179EUR$3,545USD£2,726GBP
€3532EUR$3,939USD£3,029GBP
- Report
- August 2025
- 192 Pages
Global
From €3179EUR$3,545USD£2,726GBP
€3532EUR$3,939USD£3,029GBP
- Report
- August 2025
- 181 Pages
Global
From €3179EUR$3,545USD£2,726GBP
€3532EUR$3,939USD£3,029GBP
- Report
- August 2025
- 197 Pages
Global
From €3179EUR$3,545USD£2,726GBP
€3532EUR$3,939USD£3,029GBP
- Report
- April 2025
- 70 Pages
Saudi Arabia
From €3139EUR$3,500USD£2,691GBP
- Report
- December 2024
- 85 Pages
India
From €3139EUR$3,500USD£2,691GBP
- Report
- January 2025
- 305 Pages
Global
From €4484EUR$5,000USD£3,845GBP
- Report
- June 2025
- 183 Pages
Global
From €4035EUR$4,500USD£3,460GBP
- Report
- December 2024
- 80 Pages
India
From €3139EUR$3,500USD£2,691GBP
- Report
- November 2024
- 85 Pages
United States
From €3139EUR$3,500USD£2,691GBP
From €3139EUR$3,500USD£2,691GBP
- Report
- February 2024
- 186 Pages
Global
From €4035EUR$4,500USD£3,460GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more